HALLADAY BENJAMIN (Chief Financial Officer) sold 1.5% of their position (7.34K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $26.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2025ACC: 0001628280-25-057942
Officer· Chief Financial Officer
Since Nov 2022
-7.34K
Net shares
Net seller
$26.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.34K
Price / share
$3.67
Trade value
$26.90K
% of position
1.5%
12/17/2025
474.86K→467.52K
Total
Net shares
−7.34K
Net value
-$26.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | S · Sale | −7.34K | $3.67 | $26.90K | 1.5% | 474.86K | 467.52K |
| Total | −7.34K | -$26.90K | ||||||
Derivative Transactions0
No derivative transactions reported